PROM1 and breast cancer: However, CD133+ cells have been identified in breast cancer cell lines created from Brca1-deficient murine mammary tumours and these cells were highly tumourigenic, expressed common stem cell markers and were resistant to DNA-damaging chemotherapy [79].